So I am fairly confident that the ex div date was 2/17. I

New Post Public Reply Private Reply Replies (1) Message Board
bwolfy2002
1,627
So I am fairly confident that the ex div date was 2/17. I saw this from another poster on another board. Take it or leave it but I believe them:


Them: “Sold February14th. No GNBT divi Only Antigen Express! Wierd; but, true!

DISTRIBUTION SPINOFF FROMGNBT) ANTIGEN EXPRESS CONTRA (037CNT029) Symbol 037CNT029
Description: ANTIGEN EXPRESS CONTRA
Shares +22,000.000

YOU SOLD GENEREX BIOTECHNOLOGY CORP COM USD0.001 (GNBT) (Cash)
Symbol GNBT
Description GENEREX BIOTECHNOLOGY CORP COM USD0.001
Shares -55,000.000
Price 0.649
Amount $35,694.64
Fees $0.36
Settlement Date 02/19/2020”

Me: “So you sold your shares on 2/14 and got the NGIO dividend for those shares?”

Them: “Yes, I sold GNBT shares on 2/14 and have the NGIO divi in my account today.”

So that means that now the issue at stake is in that FINRA rule about time given dictating the ex-div date. That and/or the DTC distributing under the correct rule.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Significant Leadership Transition at ForFarmers' Board

Updated Category News Views 151

Changes in ForFarmers' Supervisory Board ForFarmers has announced a pivotal change in its Supervisory Board with the upcoming departure of Erwin Wunnekink. His resignation will take effect on November 1, marking an important shift within the company’s leadership team. Wunnekink has decided to pursue a new professional opportunity that unfortunately conflicts with his...

Continue Reading
CVS Health Appoints Dr. Sreekanth Chaguturu as President of Health Care Delivery

Updated Category News Views 248

CVS Health Promotes Dr. Sreekanth Chaguturu to President CVS Health (NYSE: CVS) has announced a significant leadership change as Dr. Sreekanth Chaguturu takes on the role of President of Health Care Delivery. In addition to his current position as Executive Vice President and Chief Medical Officer, Dr. Chaguturu succeeds Mike Pykosz, who is leaving the organization after...

Continue Reading
Exxon Mobil Reports Strong Quarterly Profit Amid Challenges

Updated Category News Views 109

Exxon Mobil's Successful Quarter Amid Market Challenges Exxon Mobil showcased an impressive performance in its latest earnings report, outperforming Wall Street's expectations for the third quarter. The boost in profits came primarily from strong oil output, which benefitted from its acquisition of Pioneer Natural Resources. Financial Performance Overview The oil giant...

Continue Reading
Korn Ferry's Q1 FY2025: Strong Performance and Growth Prospects

Updated Category News Views 209

Korn Ferry's Strong Start in Q1 FY2025 Korn Ferry (NYSE: KFY), a leading global organizational consulting firm, has kicked off its first quarter of fiscal year 2025 with impressive results, surpassing expectations for both fee revenue and profitability. This achievement highlights the company's effective strategies in adapting to the changing market environment. Financial...

Continue Reading
Crescent Energy Stock Target Rises Amid Strategic Acquisitions

Updated Category News Views 184

Analyst Upgrades Crescent Energy Price Target Recently, an analyst from Stephens has revised the price target for Crescent Energy (NYSE:CRGY) shares, increasing it to $16.00 from the previous target of $15.00. This adjustment comes with an Overweight rating, indicating a bullish outlook on the stock. Earnings Forecast and Market Expectations The increase in price target...

Continue Reading